<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200129046302N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-02-26</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The Investigation of the Effects of Deep Dry Needling in Females with Episodic Tension Type Headache</public_title>
      <acronym></acronym>
      <scientific_title>The Investigation of the Effects of Deep Dry Needling into Trigger Points of Temporalis, Sternocleidomastoid  and Upper Trapezius on Females with Episodic Tension Type Headache</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-03-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>26</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45485</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be randomly assigned to the intervention or control groups. The random allocation method of these two groups will be block randomization. Block size will comprise 6 persons (overall there will be 4 blocks).
Random allocation software will be used  to determine the sequence of patient's allocation to each group, Blinding description: Pre-treatment,post-treatment assessments will be
performed by the  physiotherapist  who is supposed to be  blinded to the allocation concealment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Episodic tension type headache.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Single session treatment with deep dry needling(Dongbang model, South Korea, 50*0/3 mm)in the trigger points of the Temporalis, Sternocleidomastoid and upper Trapezius muscles in both sides(after obtaining one local twitch response ,the needle will be inserted 8 times with fast in fast out technique )following with passive stretching( 4 seconds of stretching and 8 seconds of rest , this cycle will be repeated 3 times for each muscle). Intervention 2: Control group: Single session of passive stretching in the Temporalis, Sternocleidomastoid and upper Trapezius muscles in both sides (4 seconds of stretching and 8 seconds of rest , this cycle will be repeated 3 times for each muscle).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
all data will be shared after unidentified persons.

When:
accessibility will be 6 months after printing the result.

To whom:
all researchers and scientists, working in academic and scientific institutions, can access to data.

Conditions:
Using of data is only possible by mentioning the name and organizational affiliation of the correspond and co-author of the project and the published article.

Where to obtain:
faezeh_abaschian@yahoo.com

How to obtain:
If data is used in scientific and therapeutic activities, information will be provided within 2 weeks.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Faezeh Abaschian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No18.Shahid Ahmadian Ave,Torkamenstan Str.Motahari Str</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>23478-87688</zip>
        <telephone>+98 21 8844 6048</telephone>
        <email>faezeh_abaschian@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Soheil Mansour Sohani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences, Iran University of Medical Sciences, Maddadkaran St., Shahid Nazari St., Mother Square, Mirdamad Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۴۸۷ - ۱۵۴۵۹</zip>
        <telephone>+98 21 2222 2059</telephone>
        <email>mansorsohani.s@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having a diagnosis of Episodic  tension type headache (ETTH) based on the International Classification of Headache Disorders(ICHD-3)
Having at least one active trigger point in one of the given muscles : Temporalis(Left or Right), upper Trapezius(Left or Right) , Sternocleidomastoid (Left or Right)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having  primary or secondary headaches
History of neck injury
Acute depression
History of surgery in neck and shoulder
Cervical radiculopathy
History of dry needling treatment in the neck or head for the past six months
Pregnant women</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G44.21</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Episodic tension-type headache</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Single session treatment with deep dry needling(Dongbang model, South Korea, 50*0/3 mm)in the trigger points of the Temporalis, Sternocleidomastoid and upper Trapezius muscles in both sides(after obtaining one local twitch response ,the needle will be inserted 8 times with fast in fast out technique )following with passive stretching( 4 seconds of stretching and 8 seconds of rest , this cycle will be repeated 3 times for each muscle).</i_keyword>
      <i_keyword>Control group: Single session of passive stretching in the Temporalis, Sternocleidomastoid and upper Trapezius muscles in both sides (4 seconds of stretching and 8 seconds of rest , this cycle will be repeated 3 times for each muscle).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Headache intensity. Timepoint: Headache intensity assessment at  the baseline(4 weeks before intervention) and 4 weeks after intervention. Method of measurement: Visual analogue scale.</prim_outcome>
      <prim_outcome>Headache frequency. Timepoint: Headache frequency assessment at the baseline(4 weeks before intervention) and 4 weeks after intervention. Method of measurement: The number of days with headache within 4 weeks.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Neck range of motion. Timepoint: At the beginning of the intervention , immediately , 2 and 4 weeks after intervention. Method of measurement: Goniometer.</sec_outcome>
      <sec_outcome>Mouth opening range of motion. Timepoint: At the beginning of the intervention , immediately , 2 and 4 weeks after intervention. Method of measurement: Ruler.</sec_outcome>
      <sec_outcome>Trigger points pain pressure threshold. Timepoint: At the beginning of the intervention , immediately , 2 and 4 weeks after intervention. Method of measurement: Algometer.</sec_outcome>
      <sec_outcome>Quality of life. Timepoint: before intervention and 4weeks after intervention. Method of measurement: SF-36 Quality of life Questionnaire.</sec_outcome>
      <sec_outcome>Sleep quality. Timepoint: before intervention and 4weeks after intervention. Method of measurement: Pittsburgh sleep quality questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-02-23</approval_date>
        <contact_name>•Ethics committee of Iran university of medical sciences</contact_name>
        <contact_address>Iran university of medical sciences, next to Milad tower, Hemmat highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
